17.34000 USD
0.64
3.56%
Last update Dec 15, 3:59 PM EST
Market closed
Day range
17.22000
18.17000
Previous close
17.98000
Open
18.13500
Access this stock data via API
Subscribe
Denali Therapeutics Inc.
17.34
0.64
3.56%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 0 330.5M 108.5M 48.7M
Cost of revenue
Gross profit
Operating expense
Research & development 396.4M 423.9M 358.7M 265.4M
Selling general and admin 105.4M 103.4M 90.5M 79.1M
Other operating expenses
Operating income -501.9M -196.7M -340.7M -295.8M
Non operating interest income
Income 64.6M 51.5M 14.8M 4.6M
Expense
Other income expense 14.5M
Pretax income -422.7M -145.2M -326.0M -291.2M
Tax provision 68K 30K 21K -575K
Net income -422.8M -145.2M -326.0M -290.6M
Basic EPS -2.6 -1.1 -2.6 -2.4
Diluted EPS -2.6 -1.1 -2.6 -2.4
Basic average shares 164.5M 137.4M 125.5M 121.5M
Diluted average shares 164.5M 137.4M 125.5M 121.5M
EBITDA -507.4M -180.0M -330.4M -287.2M
Net income from continuing op. -422.8M -145.2M -326.0M -290.6M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 3 hours 31 minutes

00:28
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).